AI as a Medical Device

Contacts

sophie vo Module
Sophie Vo

Associate
UK

I am a Senior Associate in the Intellectual Property Group in London with a particular focus on the life sciences and healthcare sectors.

Last month, the Medicines & Healthcare products Regulatory Agency (“MHRA“) published guidance on “Software and Artificial Intelligence (AI) as a Medical Device”. It didn’t necessarily provide for any new regulatory approach to AI in the therapeutic space, but it brought together some important material during this period of increasing interest in AI to effectively remind software providers of their compliance obligations in the life sciences and healthcare space.

Latest insights

More Insights
Curiosity line teal background

Recent Developments in Hong Kong Company Law: Key Updates for 2025

7 minutes Jan 30 2026

Read More
Curiosity line blue background

China's Pharmaceutical Regulatory Update: Faster Routes to Market, Stronger IP and Data Protection

3 minutes Jan 29 2026

Read More
featured image

UPC Court of Appeal – Two landmark decisions: What 5 things do you need to know?

7 minutes Jan 21 2026

Read More